title: [Effects of shengmai for injection on cardiogenic shock].
abstract: OBJECTIVE
  To study the protective effects and the possible mechanism of shengmai for injection(SM) against the experimental acute cardiogenic shock.
  
  
  METHODS
  The experimental acute cardiogenic shock model was established by ligating the anterior descending cornonary in dogs. The effects of SM on cardiogenic shock were investigated by measuring the hemodynamics parameter, the activity of LDH, CK, SOD and the contents of MDA in blood serum.
  
  
  RESULTS
  In the dogs treated with SM, the mean arterial pressure (MAP), heart rate (HR), left ventricular pressure (LVP), the maximum of its first derivative (+/- dp/dtmax), the cardiac output (CO) and the cardiac index (CI) were increased significantly. The left ventricular end diastolic pressure (LVEDP) and the peripheral vascular resistance (TPVR) were decreased significantly, the myocardial infarct size was redused observely. In addition, the activity of LDH, CK and the contents of MDA in serum were decreased significantly, however the activity of SOD was increased observely.
  
  
  CONCLUSIONS
  The results indicate that SM has the protective effects on cardiogenic shock.
authors.affiliation: Pharmacological laboratory, Liaoning Institute for Drug Control, Shenyang 110010, China. dxfei0578@sina.com.cn
authors.forename: Xiao-Fei
authors.initials: XF
authors.lastname: Ding
authors.forename: Guang
authors.initials: G
authors.lastname: Chen
authors.forename: Yu-Lan
authors.initials: YL
authors.lastname: Liu
mesh_terms: D000818:Animals; D002302:Cardiac Output / Q000187:drug effects; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D003402:Creatine Kinase / Q000097:blood; D004285:Dogs; D004338:Drug Combinations; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology; D007275:Injections, Intravenous; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D009203:Myocardial Infarction / Q000473:pathology / Q000517:prevention & control; D031441:Ophiopogon / Q000737:chemistry; D005894:Panax / Q000737:chemistry; D008517:Phytotherapy; D010946:Plants, Medicinal / Q000737:chemistry; D011897:Random Allocation; D032141:Schisandra / Q000737:chemistry; D012770:Shock, Cardiogenic / Q000097:blood / Q000503:physiopathology / Q000517:prevention & control*; D014655:Vascular Resistance / Q000187:drug effects
chemical_list: D002316:Cardiotonic Agents; D004338:Drug Combinations; D004365:Drugs, Chinese Herbal; C009252:fructus schizandrae, radix ginseng, radix ophiopogonis drug combination; D008315:Malondialdehyde; D007770:L-Lactate Dehydrogenase; D003402:Creatine Kinase